Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer.

IF 3 4区 医学 Q2 ONCOLOGY
İlknur Deliktaş Onur, Pınar Özdemir Akdur, Elif Sertesen Çamöz, Nazan Çiledağ, Fatih Yıldız
{"title":"Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer.","authors":"İlknur Deliktaş Onur, Pınar Özdemir Akdur, Elif Sertesen Çamöz, Nazan Çiledağ, Fatih Yıldız","doi":"10.1080/14796694.2024.2406221","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method.<b>Methods:</b> 114 colorectal cancer patients with isolated liver metastases were included in the study. Liver tumor volume, total liver volume were calculated from the patients images at the time of diagnosis. Vitrea 7.14 imaging software was used for liver volume analysis and volume analysis of each metastasis.<b>Results:</b> Median overall survival(OS) in the group with tumor volume <42 ml<sup>3</sup> was 30.98 months In the group with tumor volume ≥42 ml<sup>3</sup>, median OS was 16.36 months (<i>p</i>: 0.001). In patients who underwent metastasectomy, the median OS in the group with a tumor volume <42 ml<sup>3</sup> was 52.3 months, the median OS in the group with a tumor volume ≥42 ml<sup>3</sup> was 22.2 months. In patients who did not undergo metastasectomy, the median OS in the <42 ml<sup>3</sup> group was 20.23 months, the median OS in the ≥42 ml<sup>3</sup> group was 15.63 months.<b>Conclusion:</b> In our study, we found that liver metastasis volume was prognostic for OS. It is argued that tumor volume measurement by volumetric measurement is a widely used method in the decision for metastasectomy in liver metastatic colorectal cancer patients.</p>","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"1-8"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2024.2406221","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method.Methods: 114 colorectal cancer patients with isolated liver metastases were included in the study. Liver tumor volume, total liver volume were calculated from the patients images at the time of diagnosis. Vitrea 7.14 imaging software was used for liver volume analysis and volume analysis of each metastasis.Results: Median overall survival(OS) in the group with tumor volume <42 ml3 was 30.98 months In the group with tumor volume ≥42 ml3, median OS was 16.36 months (p: 0.001). In patients who underwent metastasectomy, the median OS in the group with a tumor volume <42 ml3 was 52.3 months, the median OS in the group with a tumor volume ≥42 ml3 was 22.2 months. In patients who did not undergo metastasectomy, the median OS in the <42 ml3 group was 20.23 months, the median OS in the ≥42 ml3 group was 15.63 months.Conclusion: In our study, we found that liver metastasis volume was prognostic for OS. It is argued that tumor volume measurement by volumetric measurement is a widely used method in the decision for metastasectomy in liver metastatic colorectal cancer patients.

通过体积测量评估结直肠癌肝转移灶体积的预后效果。
目的:采用体积测量法评估结直肠癌患者肝转移灶体积与生存率之间的关系。方法:研究纳入了114名有孤立肝转移灶的结直肠癌患者。肝脏肿瘤体积和肝脏总体积根据患者确诊时的图像计算得出。使用Vitrea 7.14成像软件进行肝脏体积分析和各转移灶的体积分析:肿瘤体积3组的中位总生存期(OS)为30.98个月,肿瘤体积≥42 ml3组的中位总生存期为16.36个月(P:0.001)。在接受转移灶切除术的患者中,肿瘤体积为 3 的组的中位生存期为 52.3 个月,肿瘤体积≥42 ml3 的组的中位生存期为 22.2 个月。在未进行转移灶切除术的患者中,肿瘤体积为3组的中位生存期为20.23个月,肿瘤体积≥42 ml3组的中位生存期为15.63个月:在我们的研究中,我们发现肝转移灶体积是OS的预后指标。因此,通过容积测量肿瘤体积是一种广泛应用于肝转移性结直肠癌患者转移切除术决策的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future oncology
Future oncology ONCOLOGY-
CiteScore
5.40
自引率
3.00%
发文量
335
审稿时长
4-8 weeks
期刊介绍: Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信